| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activator activity | 2.05e-05 | 16 | 68 | 3 | GO:0061575 | |
| GeneOntologyMolecularFunction | zinc ion binding | PAPPA2 TET2 RAG1 SETDB2 KDM5B DDAH1 ADAMTS9 MARCHF6 DTX2 TRIM6 RNF217 RNF24 | 4.20e-05 | 891 | 68 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 6.83e-05 | 4 | 68 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.70e-04 | 6 | 68 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 CRELD1 TUBB4A TUBB4B FBN1 EFEMP1 SHANK2 COL6A6 TUBB MACF1 BGLAP | 1.96e-04 | 891 | 68 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 1.99e-04 | 473 | 68 | 8 | GO:0004842 | |
| GeneOntologyMolecularFunction | calcium ion binding | CRELD1 TUBB4A FBN1 EFEMP1 LRP2 MACF1 RYR2 RYR3 BGLAP RAB11FIP3 | 2.11e-04 | 749 | 68 | 10 | GO:0005509 |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 2.69e-04 | 372 | 68 | 7 | GO:0061630 | |
| GeneOntologyMolecularFunction | hydroxyapatite binding | 3.16e-04 | 8 | 68 | 2 | GO:0046848 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 3.39e-04 | 512 | 68 | 8 | GO:0019787 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 4.04e-04 | 398 | 68 | 7 | GO:0061659 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 4.37e-04 | 532 | 68 | 8 | GO:0016755 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.52e-04 | 188 | 68 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | transition metal ion binding | PAPPA2 TET2 RAG1 SETDB2 KDM5B DDAH1 ADAMTS9 MARCHF6 DTX2 TRIM6 RNF217 RNF24 | 6.16e-04 | 1189 | 68 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase regulator activity | 7.00e-04 | 51 | 68 | 3 | GO:0016538 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.02e-03 | 58 | 68 | 3 | GO:0042287 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.10e-03 | 229 | 68 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 1.17e-03 | 15 | 68 | 2 | GO:0051011 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 1.42e-03 | 65 | 68 | 3 | GO:0016706 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.42e-03 | 65 | 68 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.69e-03 | 18 | 68 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | p53 binding | 2.31e-03 | 77 | 68 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 2.39e-03 | 78 | 68 | 3 | GO:0043539 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.06e-03 | 85 | 68 | 3 | GO:0019199 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 1.22e-06 | 25 | 67 | 4 | GO:0045737 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 1.96e-06 | 28 | 67 | 4 | GO:1904031 | |
| GeneOntologyBiologicalProcess | heart development | COL2A1 CRELD1 SIN3B SETDB2 FBN1 ADAMTS9 SMYD1 LRP2 RYR2 TP53BP2 CCND2 | 2.98e-05 | 757 | 67 | 11 | GO:0007507 |
| GeneOntologyCellularComponent | intercellular bridge | 1.48e-05 | 94 | 69 | 5 | GO:0045171 | |
| GeneOntologyCellularComponent | tubulin complex | 3.21e-05 | 3 | 69 | 2 | GO:0045298 | |
| Domain | Cyclin_D | 4.62e-08 | 3 | 68 | 3 | IPR015451 | |
| Domain | Znf_C3HC4_RING-type | 3.00e-06 | 172 | 68 | 7 | IPR018957 | |
| Domain | Beta-tubulin_BS | 5.44e-06 | 10 | 68 | 3 | IPR013838 | |
| Domain | Beta_tubulin | 5.44e-06 | 10 | 68 | 3 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 7.46e-06 | 11 | 68 | 3 | PS00228 | |
| Domain | zf-C3HC4 | 1.64e-05 | 223 | 68 | 7 | PF00097 | |
| Domain | Cyclin_C | 3.03e-05 | 17 | 68 | 3 | PF02984 | |
| Domain | Cyclin_C-dom | 3.03e-05 | 17 | 68 | 3 | IPR004367 | |
| Domain | Cyclin_C | 3.03e-05 | 17 | 68 | 3 | SM01332 | |
| Domain | Ryanrecept_TM4-6 | 3.91e-05 | 3 | 68 | 2 | IPR009460 | |
| Domain | RyR | 3.91e-05 | 3 | 68 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 3.91e-05 | 3 | 68 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 3.91e-05 | 3 | 68 | 2 | PF06459 | |
| Domain | Ryan_recept | 3.91e-05 | 3 | 68 | 2 | IPR013333 | |
| Domain | - | 5.03e-05 | 20 | 68 | 3 | 3.30.1330.20 | |
| Domain | - | 5.86e-05 | 21 | 68 | 3 | 1.10.287.600 | |
| Domain | Tubulin_C | 6.76e-05 | 22 | 68 | 3 | SM00865 | |
| Domain | Tubulin_C | 6.76e-05 | 22 | 68 | 3 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 6.76e-05 | 22 | 68 | 3 | IPR018316 | |
| Domain | - | 6.76e-05 | 22 | 68 | 3 | 3.40.50.1440 | |
| Domain | Tubulin_C | 7.76e-05 | 23 | 68 | 3 | IPR023123 | |
| Domain | TUBULIN | 7.76e-05 | 23 | 68 | 3 | PS00227 | |
| Domain | Tubulin | 7.76e-05 | 23 | 68 | 3 | IPR000217 | |
| Domain | Tub_FtsZ_C | 7.76e-05 | 23 | 68 | 3 | IPR008280 | |
| Domain | Tubulin | 7.76e-05 | 23 | 68 | 3 | SM00864 | |
| Domain | Tubulin_CS | 7.76e-05 | 23 | 68 | 3 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 8.84e-05 | 24 | 68 | 3 | IPR003008 | |
| Domain | Tubulin | 8.84e-05 | 24 | 68 | 3 | PF00091 | |
| Domain | ZF_RING_1 | 8.92e-05 | 291 | 68 | 7 | PS00518 | |
| Domain | ZF_RING_2 | 1.03e-04 | 298 | 68 | 7 | PS50089 | |
| Domain | cEGF | 1.13e-04 | 26 | 68 | 3 | IPR026823 | |
| Domain | cEGF | 1.13e-04 | 26 | 68 | 3 | PF12662 | |
| Domain | CYCLINS | 1.42e-04 | 28 | 68 | 3 | PS00292 | |
| Domain | Znf_RING | 1.80e-04 | 326 | 68 | 7 | IPR001841 | |
| Domain | RIH_assoc | 1.94e-04 | 6 | 68 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.94e-04 | 6 | 68 | 2 | IPR013662 | |
| Domain | RIH_dom | 1.94e-04 | 6 | 68 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.94e-04 | 6 | 68 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.94e-04 | 6 | 68 | 2 | IPR015925 | |
| Domain | - | 1.94e-04 | 6 | 68 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.94e-04 | 6 | 68 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 1.94e-04 | 6 | 68 | 2 | PF08709 | |
| Domain | - | 2.19e-04 | 449 | 68 | 8 | 3.30.40.10 | |
| Domain | Cyclin_N | 2.33e-04 | 33 | 68 | 3 | IPR006671 | |
| Domain | Cyclin_N | 2.33e-04 | 33 | 68 | 3 | PF00134 | |
| Domain | Znf_RING/FYVE/PHD | 2.54e-04 | 459 | 68 | 8 | IPR013083 | |
| Domain | Growth_fac_rcpt_ | 2.60e-04 | 156 | 68 | 5 | IPR009030 | |
| Domain | EGF_CA | 2.73e-04 | 86 | 68 | 4 | PF07645 | |
| Domain | VWC | 3.55e-04 | 38 | 68 | 3 | SM00214 | |
| Domain | VWFC_2 | 3.55e-04 | 38 | 68 | 3 | PS50184 | |
| Domain | CYCLIN | 3.55e-04 | 38 | 68 | 3 | SM00385 | |
| Domain | - | 4.14e-04 | 40 | 68 | 3 | 1.10.472.10 | |
| Domain | EGF_Ca-bd_CS | 4.32e-04 | 97 | 68 | 4 | IPR018097 | |
| Domain | EGF_CA | 4.66e-04 | 99 | 68 | 4 | PS01187 | |
| Domain | VWF_dom | 4.79e-04 | 42 | 68 | 3 | IPR001007 | |
| Domain | ASX_HYDROXYL | 4.85e-04 | 100 | 68 | 4 | PS00010 | |
| Domain | Cyclin-like | 5.13e-04 | 43 | 68 | 3 | IPR013763 | |
| Domain | MIR | 5.77e-04 | 10 | 68 | 2 | PS50919 | |
| Domain | MIR | 5.77e-04 | 10 | 68 | 2 | PF02815 | |
| Domain | MIR | 5.77e-04 | 10 | 68 | 2 | SM00472 | |
| Domain | MIR_motif | 5.77e-04 | 10 | 68 | 2 | IPR016093 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.04e-04 | 106 | 68 | 4 | IPR000152 | |
| Domain | RING | 8.45e-04 | 305 | 68 | 6 | SM00184 | |
| Domain | zf-RING_2 | 8.98e-04 | 52 | 68 | 3 | PF13639 | |
| Domain | EGF_CA | 1.02e-03 | 122 | 68 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.09e-03 | 124 | 68 | 4 | IPR001881 | |
| Domain | TIL_dom | 1.16e-03 | 14 | 68 | 2 | IPR002919 | |
| Domain | - | 1.33e-03 | 15 | 68 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.33e-03 | 15 | 68 | 2 | SM00501 | |
| Domain | ARID_dom | 1.33e-03 | 15 | 68 | 2 | IPR001606 | |
| Domain | ARID | 1.33e-03 | 15 | 68 | 2 | PS51011 | |
| Domain | ARID | 1.33e-03 | 15 | 68 | 2 | PF01388 | |
| Domain | EGF_3 | 1.65e-03 | 235 | 68 | 5 | PS50026 | |
| Domain | Znf_RING-CH | 1.71e-03 | 17 | 68 | 2 | IPR011016 | |
| Domain | RINGv | 1.71e-03 | 17 | 68 | 2 | SM00744 | |
| Domain | EGF-like_dom | 2.13e-03 | 249 | 68 | 5 | IPR000742 | |
| Domain | VWC_out | 2.15e-03 | 19 | 68 | 2 | SM00215 | |
| Domain | EF-hand_1 | 2.29e-03 | 152 | 68 | 4 | PF00036 | |
| Domain | EGF_1 | 2.36e-03 | 255 | 68 | 5 | PS00022 | |
| Domain | EGF-like_CS | 2.61e-03 | 261 | 68 | 5 | IPR013032 | |
| Domain | EGF_2 | 2.79e-03 | 265 | 68 | 5 | PS01186 | |
| Domain | ADAM_spacer1 | 3.15e-03 | 23 | 68 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 3.15e-03 | 23 | 68 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.42e-03 | 24 | 68 | 2 | IPR013273 | |
| Pathway | REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY | 5.59e-07 | 5 | 55 | 3 | M45016 | |
| Pathway | REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY | 5.59e-07 | 5 | 55 | 3 | MM15696 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 1.95e-06 | 7 | 55 | 3 | MM15524 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_CDK4_TO_CELL_CYCLE_G1_S | 3.10e-06 | 8 | 55 | 3 | M47419 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00483 | 4.64e-06 | 9 | 55 | 3 | M49010 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S | 6.61e-06 | 10 | 55 | 3 | M47418 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S | 9.07e-06 | 11 | 55 | 3 | M47426 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S | 1.21e-05 | 12 | 55 | 3 | M47417 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066 | 1.56e-05 | 13 | 55 | 3 | M47416 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P15_CELL_CYCLE_G1_S | 1.56e-05 | 13 | 55 | 3 | M49035 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S | 2.47e-05 | 15 | 55 | 3 | M47524 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 3.68e-05 | 17 | 55 | 3 | M27788 | |
| Pathway | REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS | 3.68e-05 | 17 | 55 | 3 | M38998 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.68e-05 | 17 | 55 | 3 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.40e-05 | 18 | 55 | 3 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.21e-05 | 19 | 55 | 3 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.21e-05 | 19 | 55 | 3 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 6.11e-05 | 20 | 55 | 3 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 6.11e-05 | 20 | 55 | 3 | M47911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 7.11e-05 | 21 | 55 | 3 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 8.21e-05 | 22 | 55 | 3 | M47903 | |
| Pathway | BIOCARTA_CELLCYCLE_PATHWAY | 9.42e-05 | 23 | 55 | 3 | M17770 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 9.42e-05 | 23 | 55 | 3 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 9.42e-05 | 23 | 55 | 3 | M47900 | |
| Pathway | BIOCARTA_CELLCYCLE_PATHWAY | 1.07e-04 | 24 | 55 | 3 | MM1376 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.07e-04 | 24 | 55 | 3 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.07e-04 | 24 | 55 | 3 | M47700 | |
| Pathway | PID_RB_1PATHWAY | 1.18e-04 | 65 | 55 | 4 | M279 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.22e-04 | 25 | 55 | 3 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.22e-04 | 25 | 55 | 3 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.37e-04 | 26 | 55 | 3 | M47672 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE | 1.49e-04 | 69 | 55 | 4 | M39339 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.66e-04 | 71 | 55 | 4 | M39690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 1.72e-04 | 28 | 55 | 3 | M47898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 2.82e-04 | 33 | 55 | 3 | M47901 | |
| Pathway | WP_MIR193A_AND_MVP_IN_COLON_CANCER_METASTASIS | 3.10e-04 | 7 | 55 | 2 | MM15853 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.37e-04 | 35 | 55 | 3 | M47774 | |
| Pathway | REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE | 4.30e-04 | 38 | 55 | 3 | M39005 | |
| Pathway | WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE | 5.71e-04 | 98 | 55 | 4 | M39524 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 6.21e-04 | 43 | 55 | 3 | M39706 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 6.21e-04 | 43 | 55 | 3 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 6.21e-04 | 43 | 55 | 3 | M47773 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 6.65e-04 | 44 | 55 | 3 | MM15377 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 7.10e-04 | 45 | 55 | 3 | M47670 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 8.04e-04 | 11 | 55 | 2 | M47958 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 8.07e-04 | 47 | 55 | 3 | M29724 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.05e-03 | 199 | 55 | 5 | M7253 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.13e-03 | 13 | 55 | 2 | M39589 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.28e-03 | 55 | 55 | 3 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.35e-03 | 56 | 55 | 3 | M2333 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 1.72e-03 | 61 | 55 | 3 | MM15912 | |
| Pathway | WP_WNT_SIGNALING | 1.72e-03 | 61 | 55 | 3 | MM15893 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.96e-03 | 17 | 55 | 2 | MM14731 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 1.98e-03 | 64 | 55 | 3 | M39627 | |
| Pathway | WP_P53_SIGNALING | 2.07e-03 | 65 | 55 | 3 | MM15852 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.15e-03 | 140 | 55 | 4 | M587 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.16e-03 | 66 | 55 | 3 | MM17074 | |
| Pathway | REACTOME_CELL_CYCLE | 2.20e-03 | 603 | 55 | 8 | MM14635 | |
| Pathway | KEGG_P53_SIGNALING_PATHWAY | 2.35e-03 | 68 | 55 | 3 | M6370 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.45e-03 | 19 | 55 | 2 | M47760 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 2.66e-03 | 71 | 55 | 3 | MM15495 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.71e-03 | 20 | 55 | 2 | MM15061 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 2.77e-03 | 72 | 55 | 3 | M27749 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 2.96e-03 | 153 | 55 | 4 | MM15522 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 2.99e-03 | 21 | 55 | 2 | M27067 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 3.23e-03 | 76 | 55 | 3 | M48037 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.23e-03 | 76 | 55 | 3 | MM14867 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 3.59e-03 | 23 | 55 | 2 | M19135 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 3.87e-03 | 81 | 55 | 3 | M748 | |
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 15576649 | ||
| Pubmed | Involvement of the D-type cyclins in germ cell proliferation and differentiation in the mouse. | 7.47e-09 | 3 | 69 | 3 | 11090462 | |
| Pubmed | Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis. | 7.47e-09 | 3 | 69 | 3 | 22289519 | |
| Pubmed | Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. | 7.47e-09 | 3 | 69 | 3 | 15755896 | |
| Pubmed | Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. | 7.47e-09 | 3 | 69 | 3 | 20090754 | |
| Pubmed | Crucial roles of D-type cyclins in the early stage of adipocyte differentiation. | 7.47e-09 | 3 | 69 | 3 | 18374658 | |
| Pubmed | Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis. | 7.47e-09 | 3 | 69 | 3 | 17882269 | |
| Pubmed | Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number. | 7.47e-09 | 3 | 69 | 3 | 22929040 | |
| Pubmed | Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. | 7.47e-09 | 3 | 69 | 3 | 15831479 | |
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 9099742 | ||
| Pubmed | Distinct patterns of expression of the D-type cyclins during testicular development in the mouse. | 2.99e-08 | 4 | 69 | 3 | 7537638 | |
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 24155149 | ||
| Pubmed | Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. | 2.99e-08 | 4 | 69 | 3 | 1827757 | |
| Pubmed | Negative regulation of TSC1-TSC2 by mammalian D-type cyclins. | 2.99e-08 | 4 | 69 | 3 | 16357142 | |
| Pubmed | Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1. | 2.99e-08 | 4 | 69 | 3 | 8887674 | |
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 16287839 | ||
| Pubmed | Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. | 2.99e-08 | 4 | 69 | 3 | 24876129 | |
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 9603423 | ||
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 11120798 | ||
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 19545277 | ||
| Pubmed | A unique function for cyclin D3 in early B cell development. | 2.99e-08 | 4 | 69 | 3 | 16582912 | |
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 27129404 | ||
| Pubmed | 7.45e-08 | 5 | 69 | 3 | 25087893 | ||
| Pubmed | Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. | 7.45e-08 | 5 | 69 | 3 | 1386336 | |
| Pubmed | Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. | 7.45e-08 | 5 | 69 | 3 | 1386335 | |
| Pubmed | Identification of G1 kinase activity for cdk6, a novel cyclin D partner. | 7.45e-08 | 5 | 69 | 3 | 8114739 | |
| Pubmed | Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells. | 7.45e-08 | 5 | 69 | 3 | 11809706 | |
| Pubmed | A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95. | 7.45e-08 | 5 | 69 | 3 | 14641107 | |
| Pubmed | 7.45e-08 | 5 | 69 | 3 | 16954383 | ||
| Pubmed | Cyclin D2 in the basal process of neural progenitors is linked to non-equivalent cell fates. | 7.45e-08 | 5 | 69 | 3 | 22395070 | |
| Pubmed | In vitro ubiquitination of cyclin D1 by ROC1-CUL1 and ROC1-CUL3. | 7.45e-08 | 5 | 69 | 3 | 11311237 | |
| Pubmed | Schizophrenia susceptibility gene product dysbindin-1 regulates the homeostasis of cyclin D1. | 7.45e-08 | 5 | 69 | 3 | 27130439 | |
| Pubmed | 1.09e-07 | 191 | 69 | 7 | 20195357 | ||
| Pubmed | USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates. | 1.49e-07 | 6 | 69 | 3 | 34425107 | |
| Pubmed | Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance. | 1.49e-07 | 6 | 69 | 3 | 37000627 | |
| Pubmed | STAT3 down-regulates the expression of cyclin D during liver development. | 1.49e-07 | 6 | 69 | 3 | 12147685 | |
| Pubmed | 1.49e-07 | 6 | 69 | 3 | 10380928 | ||
| Pubmed | Role of Fgf10 in cell proliferation in white adipose tissue. | 1.49e-07 | 6 | 69 | 3 | 16513252 | |
| Pubmed | CDK4 activity in mouse embryos expressing a single D-type cyclin. | 1.49e-07 | 6 | 69 | 3 | 18311721 | |
| Pubmed | 1.49e-07 | 6 | 69 | 3 | 17362983 | ||
| Pubmed | 1.49e-07 | 6 | 69 | 3 | 3782288 | ||
| Pubmed | 1.49e-07 | 6 | 69 | 3 | 12502747 | ||
| Pubmed | Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation. | 1.49e-07 | 6 | 69 | 3 | 16943274 | |
| Pubmed | 1.49e-07 | 6 | 69 | 3 | 9784491 | ||
| Pubmed | 1.49e-07 | 6 | 69 | 3 | 24275654 | ||
| Pubmed | 1.49e-07 | 6 | 69 | 3 | 11360184 | ||
| Pubmed | Growth suppression by p16ink4 requires functional retinoblastoma protein. | 1.49e-07 | 6 | 69 | 3 | 7603984 | |
| Pubmed | G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells. | 1.49e-07 | 6 | 69 | 3 | 28192421 | |
| Pubmed | The GATA2 transcription factor negatively regulates the proliferation of neuronal progenitors. | 2.60e-07 | 7 | 69 | 3 | 16672344 | |
| Pubmed | 2.60e-07 | 7 | 69 | 3 | 11042687 | ||
| Pubmed | Early embryonic death in mice lacking the beta-catenin-binding protein Duplin. | 2.60e-07 | 7 | 69 | 3 | 15367660 | |
| Pubmed | Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. | 2.60e-07 | 7 | 69 | 3 | 11134518 | |
| Pubmed | p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. | 2.60e-07 | 7 | 69 | 3 | 8033213 | |
| Pubmed | Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. | 3.25e-07 | 29 | 69 | 4 | 14522949 | |
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 4.16e-07 | 8 | 69 | 3 | 23246003 | |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 6.21e-07 | 247 | 69 | 7 | 39238192 | |
| Pubmed | Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. | 6.22e-07 | 9 | 69 | 3 | 15467835 | |
| Pubmed | Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. | 6.22e-07 | 9 | 69 | 3 | 24793136 | |
| Pubmed | β-catenin/cyclin D1 mediated development of suture mesenchyme in calvarial morphogenesis. | 8.88e-07 | 10 | 69 | 3 | 21108844 | |
| Pubmed | 8.88e-07 | 10 | 69 | 3 | 30738849 | ||
| Pubmed | jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. | 8.88e-07 | 10 | 69 | 3 | 12852854 | |
| Pubmed | The LxCxE pRb interaction domain of cyclin D1 is dispensable for murine development. | 8.88e-07 | 10 | 69 | 3 | 17699765 | |
| Pubmed | Arginine methyltransferase CARM1/PRMT4 regulates endochondral ossification. | 8.88e-07 | 10 | 69 | 3 | 19725955 | |
| Pubmed | Tbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1b. | 1.11e-06 | 39 | 69 | 4 | 23341776 | |
| Pubmed | 1.11e-06 | 39 | 69 | 4 | 33580754 | ||
| Pubmed | 1.22e-06 | 11 | 69 | 3 | 11748145 | ||
| Pubmed | 1.22e-06 | 11 | 69 | 3 | 19723764 | ||
| Pubmed | The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D. | 1.22e-06 | 11 | 69 | 3 | 33854239 | |
| Pubmed | The Ciliary Margin Zone of the Mammalian Retina Generates Retinal Ganglion Cells. | 1.22e-06 | 11 | 69 | 3 | 28009286 | |
| Pubmed | A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosis. | 1.36e-06 | 41 | 69 | 4 | 23509962 | |
| Pubmed | 1.62e-06 | 12 | 69 | 3 | 16537919 | ||
| Pubmed | Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex. | 1.62e-06 | 12 | 69 | 3 | 24876127 | |
| Pubmed | 2.11e-06 | 13 | 69 | 3 | 18174243 | ||
| Pubmed | 2.11e-06 | 13 | 69 | 3 | 19258477 | ||
| Pubmed | Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. | 2.11e-06 | 13 | 69 | 3 | 16237170 | |
| Pubmed | 2.11e-06 | 13 | 69 | 3 | 12538525 | ||
| Pubmed | 2.11e-06 | 13 | 69 | 3 | 11095619 | ||
| Pubmed | 2.11e-06 | 13 | 69 | 3 | 18507837 | ||
| Pubmed | 2.11e-06 | 13 | 69 | 3 | 17409409 | ||
| Pubmed | Cyclin-binding motifs are essential for the function of p21CIP1. | 2.11e-06 | 13 | 69 | 3 | 8756624 | |
| Pubmed | 2.11e-06 | 13 | 69 | 3 | 12941628 | ||
| Pubmed | Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. | 2.68e-06 | 14 | 69 | 3 | 18281541 | |
| Pubmed | 3.30e-06 | 51 | 69 | 4 | 19769959 | ||
| Pubmed | Interactions between Sox9 and beta-catenin control chondrocyte differentiation. | 3.34e-06 | 15 | 69 | 3 | 15132997 | |
| Pubmed | Transcriptional repression of p27 is essential for murine embryonic development. | 3.34e-06 | 15 | 69 | 3 | 27196371 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 22534667 | ||
| Pubmed | Cyclin D1 in excitatory neurons of the adult brain enhances kainate-induced neurotoxicity. | 3.88e-06 | 2 | 69 | 2 | 18585919 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16818732 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15504908 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 14666699 | ||
| Pubmed | Functional analysis of the human cyclin D2 and cyclin D3 promoters. | 3.88e-06 | 2 | 69 | 2 | 8621559 | |
| Pubmed | CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma. | 3.88e-06 | 2 | 69 | 2 | 30538135 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30950241 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8898078 | ||
| Pubmed | CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. | 3.88e-06 | 2 | 69 | 2 | 23255553 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11992406 | ||
| Pubmed | Expression of cyclin D1/2 in the lungs of strain A/J mice fed chemopreventive agents. | 3.88e-06 | 2 | 69 | 2 | 11872634 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21745168 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 14550562 | ||
| Pubmed | Cyclin D3 drives inertial cell cycling in dark zone germinal center B cells. | 3.88e-06 | 2 | 69 | 2 | 33332554 | |
| Interaction | DMTF1 interactions | 6.21e-06 | 11 | 69 | 3 | int:DMTF1 | |
| GeneFamily | Ring finger proteins | 1.27e-06 | 275 | 53 | 8 | 58 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.52e-05 | 3 | 53 | 2 | 287 | |
| GeneFamily | Tubulins | 5.90e-05 | 26 | 53 | 3 | 778 | |
| GeneFamily | Cyclins | 7.40e-05 | 28 | 53 | 3 | 473 | |
| GeneFamily | AT-rich interaction domain containing | 8.64e-04 | 15 | 53 | 2 | 418 | |
| GeneFamily | EF-hand domain containing | 3.86e-03 | 219 | 53 | 4 | 863 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.45e-03 | 34 | 53 | 2 | 487 | |
| GeneFamily | Ankyrin repeat domain containing | 5.49e-03 | 242 | 53 | 4 | 403 | |
| GeneFamily | Collagens | 8.04e-03 | 46 | 53 | 2 | 490 | |
| Coexpression | BAKER_HEMATOPOESIS_STAT5_TARGETS | 6.06e-07 | 7 | 69 | 3 | M1165 | |
| Coexpression | BAKER_HEMATOPOESIS_STAT5_TARGETS | 6.06e-07 | 7 | 69 | 3 | MM1110 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RSBN1 KDM5B SETX NALF1 CRIM1 MARCHF6 MACF1 CCND1 CAMSAP2 TP53BP1 TP53BP2 SNX13 | 2.17e-06 | 856 | 69 | 12 | M4500 |
| Coexpression | NABA_CORE_MATRISOME | 7.12e-06 | 270 | 69 | 7 | MM17057 | |
| Coexpression | BAKER_HEMATOPOIESIS_STAT3_TARGETS | 7.77e-06 | 15 | 69 | 3 | M1163 | |
| Coexpression | BAKER_HEMATOPOIESIS_STAT3_TARGETS | 7.77e-06 | 15 | 69 | 3 | MM1109 | |
| Coexpression | NABA_CORE_MATRISOME | 8.03e-06 | 275 | 69 | 7 | M5884 | |
| Coexpression | NABA_MATRISOME | COL2A1 PAPPA2 CRELD1 FBN1 EFEMP1 CRIM1 COL6A6 ADAMTS9 MUC19 ADAMTSL2 BGLAP | 6.09e-05 | 1008 | 69 | 11 | MM17056 |
| Coexpression | NABA_MATRISOME | COL2A1 PAPPA2 CRELD1 FBN1 EFEMP1 CRIM1 COL6A6 ADAMTS9 MUC19 ADAMTSL2 BGLAP | 7.14e-05 | 1026 | 69 | 11 | M5889 |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 9.85e-05 | 34 | 69 | 3 | M14043 | |
| Coexpression | GERHOLD_RESPONSE_TO_TZD_UP | 1.02e-04 | 6 | 69 | 2 | MM879 | |
| Coexpression | GERHOLD_RESPONSE_TO_TZD_UP | 1.02e-04 | 6 | 69 | 2 | M2040 | |
| Coexpression | NABA_MATRISOME_INSULINOMA | 1.42e-04 | 7 | 69 | 2 | MM17050 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.50e-04 | 191 | 69 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.69e-04 | 196 | 69 | 5 | M3008 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 1.82e-04 | 199 | 69 | 5 | M5159 | |
| Coexpression | GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN | 1.86e-04 | 200 | 69 | 5 | M4459 | |
| Coexpression | GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP | 1.86e-04 | 200 | 69 | 5 | M4301 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 2.05e-04 | 322 | 69 | 6 | M39060 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000 | TET2 RSBN1 TMEM174 DDAH1 TSPAN18 ADAMTS9 LRP2 TRIM6 CAMSAP2 RYR2 RYR3 RAB11FIP3 | 4.56e-06 | 758 | 68 | 12 | gudmap_developingKidney_e15.5_Proximal Tubules_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.14e-05 | 280 | 68 | 7 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k5 | |
| CoexpressionAtlas | alpha beta T cells, T.4int8+.Th, 4int 8+ TCRhi, Thymus, avg-3 | 3.84e-05 | 289 | 68 | 7 | GSM399367_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | RSBN1 CRELD1 SIN3B TMEM174 DDAH1 TSPAN18 LRP2 MACF1 CCND1 CAMSAP2 BGLAP | 4.95e-05 | 811 | 68 | 11 | gudmap_developingKidney_e15.5_S-shaped body_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.27e-04 | 350 | 68 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#4_top-relative-expression-ranked_500 | 1.91e-04 | 89 | 68 | 4 | gudmap_developingKidney_e15.5_S-shaped body_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.08e-04 | 91 | 68 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.33e-04 | 173 | 68 | 5 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.33e-04 | 173 | 68 | 5 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.53e-04 | 176 | 68 | 5 | gudmap_developingKidney_e15.5_S-shaped body_1000_k3 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-08 | 178 | 69 | 7 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-08 | 178 | 69 | 7 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.44e-07 | 178 | 69 | 6 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.91e-07 | 182 | 69 | 6 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.04e-07 | 183 | 69 | 6 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.17e-07 | 184 | 69 | 6 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.88e-07 | 189 | 69 | 6 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-07 | 190 | 69 | 6 | 00fd993675faf53adf985b9316a18c8a33242029 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-07 | 190 | 69 | 6 | 8cda09d761c6b504a744959d587c183f94f1beeb | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 6.60e-07 | 199 | 69 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 6.60e-07 | 199 | 69 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.71e-06 | 170 | 69 | 5 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-06 | 174 | 69 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-06 | 174 | 69 | 5 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.94e-06 | 176 | 69 | 5 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.94e-06 | 176 | 69 | 5 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 8.62e-06 | 179 | 69 | 5 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-06 | 182 | 69 | 5 | bdeebbfffc1308a29b721a5f8fed23a28d7a2f2f | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-06 | 182 | 69 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-06 | 182 | 69 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-06 | 183 | 69 | 5 | 92f54c267135cb5edbcacd26a0f29e62469bb7e5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-06 | 183 | 69 | 5 | 5c4f7d02ba3a3c4a22ac71302e7c9a47e205eef5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-06 | 184 | 69 | 5 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-06 | 184 | 69 | 5 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.01e-05 | 185 | 69 | 5 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | P15-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-05 | 187 | 69 | 5 | 60f41b1f1b656d211b80398aa2cf0ac0cdad9372 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.06e-05 | 187 | 69 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | P15-Endothelial-unknown_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-05 | 187 | 69 | 5 | d543ddc63f864b6d0982c4ff652af174af085c4a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.09e-05 | 188 | 69 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.09e-05 | 188 | 69 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.12e-05 | 189 | 69 | 5 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-05 | 191 | 69 | 5 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-05 | 191 | 69 | 5 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-05 | 191 | 69 | 5 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.24e-05 | 193 | 69 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 69 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.27e-05 | 194 | 69 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-05 | 195 | 69 | 5 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-05 | 195 | 69 | 5 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 195 | 69 | 5 | b67d4f34cae729c18275486d3b20c9dd7d5cbe79 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.30e-05 | 195 | 69 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.34e-05 | 196 | 69 | 5 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(0)_uninjured|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 1.39e-05 | 4 | 69 | 2 | 69b42d11bfc5d1a856263b5d3bf618a83ca4ceeb | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.44e-05 | 199 | 69 | 5 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-05 | 116 | 69 | 4 | cf4e3c34570f57502ec524881d351ef8e47976d2 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.40e-05 | 126 | 69 | 4 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.60e-05 | 134 | 69 | 4 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.93e-05 | 136 | 69 | 4 | 9cf076597e6fd9390850fda259daa13022f15893 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.45e-05 | 149 | 69 | 4 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 160 | 69 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 160 | 69 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 161 | 69 | 4 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 161 | 69 | 4 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.14e-04 | 161 | 69 | 4 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 161 | 69 | 4 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 162 | 69 | 4 | 1f1b93394b1f27cbb76b369c19b9313609edd577 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 162 | 69 | 4 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.19e-04 | 163 | 69 | 4 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.19e-04 | 163 | 69 | 4 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 164 | 69 | 4 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 167 | 69 | 4 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.31e-04 | 167 | 69 | 4 | 1c1b4722c6c0eff85a9b32ca7b4e281caebf63b0 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 167 | 69 | 4 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-04 | 168 | 69 | 4 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_Tfh|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.37e-04 | 169 | 69 | 4 | ad9054ee09033b648a76baf1b2ec4a6ab1394bde | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-04 | 170 | 69 | 4 | 667443062882642211ad116043775ef8eda38859 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 173 | 69 | 4 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 175 | 69 | 4 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 175 | 69 | 4 | 21542be95059983d2c8bdf01ec711fdbf1ec1f62 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 176 | 69 | 4 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 177 | 69 | 4 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-04 | 178 | 69 | 4 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 178 | 69 | 4 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-04 | 179 | 69 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-04 | 180 | 69 | 4 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 180 | 69 | 4 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Kidney|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 180 | 69 | 4 | 7e5f497699876ac8e1ce780626c6f5a1f6f5f079 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 180 | 69 | 4 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 180 | 69 | 4 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 181 | 69 | 4 | bec7076efe94898213a62db72d171d737949977e | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 181 | 69 | 4 | cf149b30b814cf87c9e923ef502cadf7fe4a3597 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 181 | 69 | 4 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-04 | 181 | 69 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 181 | 69 | 4 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 182 | 69 | 4 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.82e-04 | 182 | 69 | 4 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 182 | 69 | 4 | ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 182 | 69 | 4 | faf0dfa3adc2d2706b6942b5127093ccdc856447 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.82e-04 | 182 | 69 | 4 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 182 | 69 | 4 | be8dd52898525ce6632af0adc2801944f3ac10bd | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.86e-04 | 183 | 69 | 4 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 183 | 69 | 4 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.86e-04 | 183 | 69 | 4 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-04 | 184 | 69 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 184 | 69 | 4 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-04 | 184 | 69 | 4 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| Drug | AC1O5Y0F | 4.46e-06 | 37 | 68 | 4 | CID006442852 | |
| Drug | Epothilone D | 5.50e-06 | 12 | 68 | 3 | DB01873 | |
| Drug | dineolignan | 5.50e-06 | 12 | 68 | 3 | CID005316907 | |
| Drug | Epothilone B | 5.50e-06 | 12 | 68 | 3 | DB03010 | |
| Drug | ABT-751 | 9.03e-06 | 44 | 68 | 4 | CID003035714 | |
| Drug | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone | 1.13e-05 | 15 | 68 | 3 | ctd:C120275 | |
| Drug | galgravin | 1.39e-05 | 16 | 68 | 3 | CID000101749 | |
| Drug | CPG-oligonucleotide | 1.85e-05 | 184 | 68 | 6 | ctd:C408982 | |
| Drug | 2-hydroxycarbazole | 2.63e-05 | 3 | 68 | 2 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 2.63e-05 | 3 | 68 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 2.63e-05 | 3 | 68 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.63e-05 | 3 | 68 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 2.63e-05 | 3 | 68 | 2 | CID000127713 | |
| Drug | aminodantrolene | 2.63e-05 | 3 | 68 | 2 | CID009570289 | |
| Drug | Berberine | 3.14e-05 | 202 | 68 | 6 | ctd:D001599 | |
| Drug | bromocolchicine | 3.26e-05 | 21 | 68 | 3 | CID000161518 | |
| Drug | Ustiloxin A | 3.26e-05 | 21 | 68 | 3 | CID000164454 | |
| Drug | SRI-3072 | 3.26e-05 | 21 | 68 | 3 | CID000493469 | |
| Drug | colchifoline | 3.26e-05 | 21 | 68 | 3 | CID000100132 | |
| Drug | 3,4,5-trimethoxyacetophenone | 3.77e-05 | 22 | 68 | 3 | CID000014345 | |
| Drug | AC1L1GIQ | 3.77e-05 | 22 | 68 | 3 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 3.77e-05 | 22 | 68 | 3 | CID000098538 | |
| Drug | SureCN13401588 | 3.77e-05 | 22 | 68 | 3 | CID009897422 | |
| Drug | di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | 3.77e-05 | 22 | 68 | 3 | ctd:C539263 | |
| Drug | N-methyldemecolcine | 3.77e-05 | 22 | 68 | 3 | CID000023759 | |
| Drug | NSC-339672 | 3.77e-05 | 22 | 68 | 3 | CID000433930 | |
| Drug | Thapsigargin | CRELD1 TUBB4A TUBB4B DDAH1 ARID4B ADAMTS9 RNF181 TUBB MACF1 CCND1 PRORP PPP1R15A TAF1L TP53BP2 | 3.83e-05 | 1353 | 68 | 14 | ctd:D019284 |
| Drug | IKP104 | 4.32e-05 | 23 | 68 | 3 | CID000130739 | |
| Drug | fluorescein-colchicine | 4.32e-05 | 23 | 68 | 3 | CID003035871 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 4.32e-05 | 23 | 68 | 3 | CID000006858 | |
| Drug | 3-demethylthiocolchicine | 4.32e-05 | 23 | 68 | 3 | CID000084076 | |
| Drug | 2,3,4-TCB | 4.32e-05 | 23 | 68 | 3 | CID000129239 | |
| Drug | AC1L2P05 | 4.32e-05 | 23 | 68 | 3 | CID000125688 | |
| Drug | 2,3,4-tabp | 4.32e-05 | 23 | 68 | 3 | CID000125548 | |
| Drug | NSC-373301 | 4.32e-05 | 23 | 68 | 3 | CID000341375 | |
| Drug | N-acetylcolchinol | 4.32e-05 | 23 | 68 | 3 | CID000097865 | |
| Drug | NSC355636 | 4.32e-05 | 23 | 68 | 3 | CID000100176 | |
| Drug | moscatilin | 4.93e-05 | 24 | 68 | 3 | CID000176096 | |
| Drug | parbendazole | 4.93e-05 | 24 | 68 | 3 | CID000026596 | |
| Drug | NSC-36768 | 4.93e-05 | 24 | 68 | 3 | CID000165441 | |
| Drug | deacetamidocolchicine | 4.93e-05 | 24 | 68 | 3 | CID000014995 | |
| Drug | tropolone methyl ether | 4.93e-05 | 24 | 68 | 3 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 4.93e-05 | 24 | 68 | 3 | CID000330401 | |
| Drug | NABV | 4.93e-05 | 24 | 68 | 3 | CID000175959 | |
| Drug | colchicide | 4.93e-05 | 24 | 68 | 3 | CID000120712 | |
| Drug | AC1L4TG7 | 4.93e-05 | 24 | 68 | 3 | CID000163705 | |
| Drug | THRX 165724 | 5.25e-05 | 4 | 68 | 2 | ctd:C475928 | |
| Drug | PCB74 | 5.25e-05 | 4 | 68 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 5.25e-05 | 4 | 68 | 2 | CID006444275 | |
| Drug | 5-((5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-N-(2-hydroxy-3-morpholin-4-ylpropyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide | 5.25e-05 | 4 | 68 | 2 | ctd:C513935 | |
| Drug | SC 38249 | 5.25e-05 | 4 | 68 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 5.25e-05 | 4 | 68 | 2 | CID000035682 | |
| Drug | Cyl-2 | 5.25e-05 | 4 | 68 | 2 | CID000162495 | |
| Drug | ixabepilone | 5.43e-05 | 69 | 68 | 4 | CID006445540 | |
| Drug | NBD-colcemid | 5.59e-05 | 25 | 68 | 3 | CID000130594 | |
| Drug | mpMap | 5.59e-05 | 25 | 68 | 3 | CID000100806 | |
| Drug | AC1Q6P06 | 5.59e-05 | 25 | 68 | 3 | CID000160263 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 5.59e-05 | 25 | 68 | 3 | CID000043264 | |
| Drug | allocolchicine | 5.59e-05 | 25 | 68 | 3 | CID000196989 | |
| Drug | 1069C85 | 5.59e-05 | 25 | 68 | 3 | CID006918099 | |
| Drug | 55623-37-5 | 5.59e-05 | 25 | 68 | 3 | CID006438440 | |
| Drug | CA1P | 5.59e-05 | 25 | 68 | 3 | CID006918545 | |
| Drug | peloruside A | 5.59e-05 | 25 | 68 | 3 | CID006918506 | |
| Drug | NSC142227 | 5.59e-05 | 25 | 68 | 3 | CID000073427 | |
| Drug | MDL 27048 | 5.59e-05 | 25 | 68 | 3 | CID006439188 | |
| Drug | NSC527981 | 6.31e-05 | 26 | 68 | 3 | CID000352796 | |
| Drug | NSC332029 | 6.31e-05 | 26 | 68 | 3 | CID000100073 | |
| Drug | indibulin | 6.31e-05 | 26 | 68 | 3 | CID000002929 | |
| Drug | pironetin | 6.31e-05 | 26 | 68 | 3 | CID006438891 | |
| Drug | isaxonine | 6.31e-05 | 26 | 68 | 3 | CID000071169 | |
| Drug | AC1L1J4H | 7.08e-05 | 27 | 68 | 3 | CID000004862 | |
| Drug | Everolimus | 7.08e-05 | 27 | 68 | 3 | ctd:D000068338 | |
| Drug | NSC292222 | 7.08e-05 | 27 | 68 | 3 | CID000099957 | |
| Drug | dinitroanilines | 7.08e-05 | 27 | 68 | 3 | CID000136400 | |
| Drug | NSC D-669356 | 7.08e-05 | 27 | 68 | 3 | CID000178028 | |
| Drug | NSC 370147 | 7.91e-05 | 28 | 68 | 3 | CID000182762 | |
| Drug | NSC72302 | 7.91e-05 | 28 | 68 | 3 | CID000118078 | |
| Drug | bp U | 8.81e-05 | 29 | 68 | 3 | CID000368697 | |
| Drug | Aids106696 | 8.81e-05 | 29 | 68 | 3 | CID006475933 | |
| Drug | ddGDP | 8.81e-05 | 29 | 68 | 3 | CID000134739 | |
| Drug | oxibendazole | 8.81e-05 | 29 | 68 | 3 | CID000004622 | |
| Drug | procaine | 9.51e-05 | 153 | 68 | 5 | CID000004914 | |
| Drug | 2,4-xylidinothiazoline | 9.76e-05 | 30 | 68 | 3 | CID000099296 | |
| Drug | AC1NBBHE | 9.76e-05 | 30 | 68 | 3 | CID004490620 | |
| Drug | eleutherobin | 9.76e-05 | 30 | 68 | 3 | CID006918335 | |
| Drug | azatoxin | 9.76e-05 | 30 | 68 | 3 | CID000125383 | |
| Drug | NSC617668 | 9.76e-05 | 30 | 68 | 3 | CID000357989 | |
| Drug | citostal | 9.76e-05 | 30 | 68 | 3 | CID000018991 | |
| Drug | thiocolchicine | 9.76e-05 | 30 | 68 | 3 | CID000017648 | |
| Drug | tropone | 1.08e-04 | 31 | 68 | 3 | CID000010881 | |
| Drug | NSC609395 | 1.08e-04 | 31 | 68 | 3 | CID005488798 | |
| Drug | amiprophosmethyl | 1.08e-04 | 31 | 68 | 3 | CID000100524 | |
| Drug | AC7700 | 1.08e-04 | 31 | 68 | 3 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 1.08e-04 | 31 | 68 | 3 | CID000032851 | |
| Drug | AC1L3V8I | 1.08e-04 | 31 | 68 | 3 | CID000122777 | |
| Drug | NSC332598 | 1.08e-04 | 31 | 68 | 3 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 1.08e-04 | 31 | 68 | 3 | CID000023678 | |
| Drug | AC1L1G95 | 1.19e-04 | 32 | 68 | 3 | CID000003583 | |
| Drug | E2-3,4-Q | 1.19e-04 | 32 | 68 | 3 | CID000067402 | |
| Drug | NSC153858 | 1.19e-04 | 32 | 68 | 3 | CID000547450 | |
| Disease | colon adenoma (is_marker_for) | 4.07e-07 | 7 | 68 | 3 | DOID:0050912 (is_marker_for) | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 6.50e-07 | 8 | 68 | 3 | DOID:14452 (implicated_via_orthology) | |
| Disease | facial paralysis (implicated_via_orthology) | 1.39e-06 | 10 | 68 | 3 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 1.39e-06 | 10 | 68 | 3 | DOID:0090132 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 1.39e-06 | 10 | 68 | 3 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 1.39e-06 | 10 | 68 | 3 | DOID:0112227 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 2.54e-06 | 12 | 68 | 3 | DOID:0050997 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.57e-05 | 3 | 68 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.57e-05 | 3 | 68 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | peak expiratory flow | 1.89e-05 | 498 | 68 | 8 | EFO_0009718 | |
| Disease | invasive lobular carcinoma (is_implicated_in) | 3.13e-05 | 4 | 68 | 2 | DOID:3457 (is_implicated_in) | |
| Disease | Geleophysic dysplasia | 5.21e-05 | 5 | 68 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 5.21e-05 | 5 | 68 | 2 | C0265287 | |
| Disease | multiple myeloma (is_marker_for) | 7.91e-05 | 36 | 68 | 3 | DOID:9538 (is_marker_for) | |
| Disease | birth weight, parental genotype effect measurement | 8.28e-05 | 192 | 68 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | high grade glioma (is_marker_for) | 1.26e-04 | 42 | 68 | 3 | DOID:3070 (is_marker_for) | |
| Disease | serum IgG glycosylation measurement | 2.01e-04 | 523 | 68 | 7 | EFO_0005193 | |
| Disease | sexual dimorphism measurement | CCND3 PAPPA2 TET2 FBN1 EFEMP1 CRIM1 MACF1 TP53BP1 SNX13 CCND2 | 2.12e-04 | 1106 | 68 | 10 | EFO_0021796 |
| Disease | Sensory hearing loss | 2.84e-04 | 11 | 68 | 2 | C1691779 | |
| Disease | Colonic Neoplasms | 4.27e-04 | 152 | 68 | 4 | C0009375 | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 4.68e-04 | 14 | 68 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 5.05e-04 | 67 | 68 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | Malignant tumor of colon | 5.06e-04 | 159 | 68 | 4 | C0007102 | |
| Disease | Prostatic Neoplasms | 5.38e-04 | 616 | 68 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.38e-04 | 616 | 68 | 7 | C0376358 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 5.39e-04 | 15 | 68 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 5.39e-04 | 15 | 68 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | Crohn's disease | 5.39e-04 | 441 | 68 | 6 | EFO_0000384 | |
| Disease | total blood protein measurement | 5.93e-04 | 449 | 68 | 6 | EFO_0004536 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 6.15e-04 | 16 | 68 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 6.15e-04 | 16 | 68 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 6.15e-04 | 16 | 68 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 6.15e-04 | 16 | 68 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 6.15e-04 | 16 | 68 | 2 | C3541456 | |
| Disease | body surface area | 6.93e-04 | 643 | 68 | 7 | EFO_0022196 | |
| Disease | Van Buchem disease | 6.96e-04 | 17 | 68 | 2 | C0432272 | |
| Disease | central corneal thickness | 7.41e-04 | 309 | 68 | 5 | EFO_0005213 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 8.21e-04 | 181 | 68 | 4 | DOID:684 (is_implicated_in) | |
| Disease | Dyschondroplasias | 8.72e-04 | 19 | 68 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 8.72e-04 | 19 | 68 | 2 | C0029422 | |
| Disease | macula measurement | 9.64e-04 | 189 | 68 | 4 | EFO_0008375 | |
| Disease | Multiple Epiphyseal Dysplasia | 9.68e-04 | 20 | 68 | 2 | C0026760 | |
| Disease | Colorectal Carcinoma | 1.15e-03 | 702 | 68 | 7 | C0009402 | |
| Disease | impotence (biomarker_via_orthology) | 1.17e-03 | 22 | 68 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | Nasopharyngeal carcinoma | 1.17e-03 | 22 | 68 | 2 | C2931822 | |
| Disease | Sensorineural Hearing Loss (disorder) | 1.28e-03 | 23 | 68 | 2 | C0018784 | |
| Disease | alpha fetoprotein measurement | 1.61e-03 | 100 | 68 | 3 | EFO_0010583 | |
| Disease | Heart valve disease | 1.64e-03 | 26 | 68 | 2 | C0018824 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.76e-03 | 103 | 68 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | lean body mass | 1.83e-03 | 379 | 68 | 5 | EFO_0004995 | |
| Disease | Hyperplasia | 1.90e-03 | 28 | 68 | 2 | C0020507 | |
| Disease | osteoarthritis (is_implicated_in) | 1.90e-03 | 28 | 68 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | handedness | 1.91e-03 | 106 | 68 | 3 | EFO_0009902 | |
| Disease | urinary bladder cancer (is_marker_for) | 1.96e-03 | 107 | 68 | 3 | DOID:11054 (is_marker_for) | |
| Disease | forced expiratory volume | 2.24e-03 | 789 | 68 | 7 | EFO_0004314 | |
| Disease | alkaline phosphatase measurement | 2.27e-03 | 1015 | 68 | 8 | EFO_0004533 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVCPDCSDEIAVKKD | 196 | Q4LE39 | |
| EPTEREKVELAAECC | 581 | Q92888 | |
| EVCEEQRCEEEVFPL | 66 | P30281 | |
| VVDDLRLCSVKPCED | 311 | Q96P50 | |
| EVCEEQKCEEEVFPL | 66 | P24385 | |
| VIREDPSILECCDSE | 46 | Q3KP44 | |
| TICRDVVDLCKEPGE | 26 | Q13625 | |
| DIICEDVKDCLSPEI | 66 | P02458 | |
| VKCPAKECNEEVSLE | 356 | P15918 | |
| CTPCLKANIERLEEE | 561 | O75154 | |
| EPDVEACIAVCSARI | 1536 | Q96PE2 | |
| VCEEQKCEEEVFPLA | 66 | P30279 | |
| SKCLDVDECETEVCP | 301 | Q96HD1 | |
| RIDCTPDQEVTEDIC | 51 | Q2M2H8 | |
| TEELKVPPDEDCIIC | 401 | Q86UW9 | |
| DIRAEEERGECSPKC | 201 | Q9UJ96 | |
| DRSCDVEDVPVDGCT | 1101 | Q7Z5P9 | |
| VEDKCEKACRPEEEC | 186 | P55259 | |
| EKECLCEEGVTPLVE | 471 | O94854 | |
| EDICRVCRSEGTPEK | 6 | O60337 | |
| CEAAEAVRPEERKTC | 666 | Q86TH1 | |
| EQEKTQEERCSEPCL | 536 | A0A1B0GV03 | |
| DFELLPDDERQCVKC | 681 | Q9UGL1 | |
| DKRTCVDIDECTEMP | 3146 | P98164 | |
| LEVCILECEEKVFPS | 41 | Q13519 | |
| REVCELNPDCDELAD | 71 | P02818 | |
| EEKECLVPLCGEEEN | 441 | Q8NB91 | |
| DLDECTCRDPKAEEN | 1776 | Q9BXP8 | |
| CVERIKPDEQRACES | 1366 | Q9P2N4 | |
| EDTRVCDDVNECETP | 1641 | P35555 | |
| DPSRLEEEVKRCLSC | 506 | Q8ND71 | |
| RIEEEKPDCSKARCE | 166 | Q9NZV1 | |
| LCAAETDVEDPEVEC | 776 | Q8WXE1 | |
| DDKSECPCPEEIRDQ | 1981 | Q92736 | |
| CPDVVRLEDICLKET | 266 | Q08AD1 | |
| LPDCVFVEDVAVVCE | 71 | O94760 | |
| CSPREECKRIEVLDV | 796 | A6NMZ7 | |
| CCPAVEEEDDEEAVK | 186 | O75807 | |
| DPVRQQCKDIDECDI | 36 | Q12805 | |
| CVRIKTESEEACTEI | 736 | Q5VWQ0 | |
| KEVCRDLVCTSPKDE | 206 | Q9Y5W8 | |
| LECPVCKEDYTVEEE | 226 | Q9Y4L5 | |
| CPVCLLEFEEEETAI | 76 | Q9P0P0 | |
| TEEEIRAKVSPEQCC | 891 | Q8IZX4 | |
| LCRECLEKQEPVFAD | 331 | Q8NB12 | |
| KCDDPEEELCHRREA | 2621 | Q7Z333 | |
| EEDEDMVPCKTLCET | 1126 | O75182 | |
| ELCAVCLEDFKPRDE | 76 | Q9Y225 | |
| EIKCPITECFEFLEE | 301 | Q8TC41 | |
| DEDLVERCSCEVPTK | 561 | O15091 | |
| PAECVEEVQCKPRDS | 576 | Q9UPX8 | |
| EVEEIDQCTKPRDCP | 41 | Q9BQY6 | |
| KLEVACSDCEVEVLP | 431 | Q96T68 | |
| EEELESENAPVCDRC | 426 | Q9UK80 | |
| DIVICDEECDSPESV | 106 | Q9UID6 | |
| IPEENRCVDILELCE | 1536 | Q15413 | |
| VLDVVRKEAESCDCL | 116 | P04350 | |
| CKRKRECLDESDDEP | 196 | A6NKU9 | |
| VLDVVRKEAESCDCL | 116 | P68371 | |
| VLDVVRKEAESCDCL | 116 | P07437 | |
| DCVSEVEIIAEPCRV | 971 | Q68DE3 | |
| EETEEPIVECQECET | 1271 | Q12888 | |
| CLPEDKEVLTEDKCL | 431 | P22314 | |
| LSCQLCKESEERVPD | 96 | Q8WUU8 | |
| TLDSEEVPEACCRRE | 166 | Q96SJ8 | |
| PSCRCVEQIIEKDEG | 1131 | Q6N021 | |
| TLIDEGVERCCESPV | 376 | Q04912 | |
| LVDIREEVTCPICLE | 6 | Q9C030 | |
| NDEPECCDVRREEKS | 371 | B1AL88 |